Press release
Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever.PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By reducing immunogenicity and proteolytic degradation, PEGylation allows for safer and more effective drug formulations. Monodispersed PEGs are gaining attention in the industry, despite only two approved drugs utilizing them.
Movantik, featuring an m-PEG7 linker, exemplifies the significant advantages of monodisperse PEGylation, resulting in improved solubility, bioavailability, and pharmacokinetics compared to traditional approaches. Asclera (Polidocanol) is another notable example, incorporating an m-PEG9 entity that can function as a local anesthetic in topical ointments or as an injectable treatment for varicose veins, showcasing the versatility of PEGylated formulations.
"Our aim at Biopharma PEG is to empower your PEGylated drug development with innovative solutions that enhance therapeutic outcomes," said Jack Deng, CEO at Biopharma PEG. "We are committed to providing high-quality PEG products that meet the diverse needs of pharmaceutical companies."
As the biopharmaceutical landscape evolves, Biopharma PEG is dedicated to offering superior PEGylation solutions. For more information about our products and how we can assist in your PEGylated drug development, please visit www.biochempeg.com or contact us at sales@biochempeg.com.
Biopharma PEG Scientific Inc.
108 Water Street, Suite 4D, Watertown, MA 02472, USA
TEL: 1-857-928-2050 / 1-857-366-6766
Fax: 617-206-9595
Email: sales@biochempeg.com
Biopharma PEG specializes in providing cutting-edge PEGylation solutions for the biopharmaceutical industry. Our diverse portfolio of PEG products and tailored services supports researchers and developers in creating more effective and safer therapies
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy here
News-ID: 3714930 • Views: …
More Releases from Biopharma PEG Scientific Inc
BIOPHARMA PEG Receives FDA DMF Listings for Two Key PEG Derivatives
BIOPHARMA PEG, a leading developer and supplier of high-purity polyethylene glycol (PEG) derivatives, today announced that two of its proprietary products-mPEG-pALD 20K and HZ-PEG-HZ (1K)-have successfully passed FDA review and are now listed in the U.S. Drug Master File (DMF) database.
mPEG-pALD (20K) - DMF No. 040600
HZ-PEG-HZ (1K) - DMF No. 041864
These new listings mark a significant step in BIOPHARMA PEG's ongoing efforts to provide regulatory-ready, high-quality PEG solutions to the…
Monodispersed PEG Linkers Enhance Antibody-Drug Conjugates (ADCs)
Antibody-drug conjugates (ADCs) combine potent small-molecule drugs with monoclonal antibodies for targeted cancer therapy. A major challenge is loading enough drug onto each antibody without compromising solubility or circulation time. Introducing polyethylene glycol (PEG) linkers between the antibody and drug payload can address this. PEG is hydrophilic, biologically inert, and FDA‐recognized as safe. As a flexible spacer, PEG "shields" the hydrophobic drug, greatly improving ADC solubility and stability. In fact,…
Biopharma PEG Scientific Inc. to Showcase Comprehensive PEG Derivative Portfolio …
Biopharma PEG Scientific Inc., a leading provider of high-quality polyethylene glycol (PEG) derivatives, today announced its participation in TIDES USA 2025, taking place from May 19 - 22, 2025, at the Manchester Grand Hyatt San Diego. Attendees are invited to visit Biopharma PEG at Booth #913 to explore their extensive range of GMP-grade PEG products and discuss how these solutions can advance their research and development efforts.
Biopharma PEG offers a…
BIOPHARMA PEG Showcases DSPE-PEG-Mannose: A Cutting-Edge Polymer for Drug Delive …
Watertown, MA - March 24, 2025 - Biopharma PEG, a leading supplier of high-quality polyethylene glycol (PEG) derivatives, highlights its innovative product DSPE-PEG-Mannose, an advanced biomedical polymer with significant potential in drug delivery, tumor-targeted therapy, tissue recognition, and adhesion.
Structural Advantages of DSPE-PEG-Mannose
DSPE-PEG-Mannose is composed of three key components that enable its diverse applications:
DSPE (1,2-Distearoyl-sn-glycero-3-phosphoethanolamine): A phospholipid with amphiphilic properties, forming stable micelles in aqueous solutions.
PEG (Polyethylene Glycol): A biocompatible polymer…
More Releases for PEGylation
PEGylation Market Insights, Forecast to 2029 Market Analysis & Forecast for Next …
The PEGylation Market Insights, Forecast to 2029 market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present…
Growth Prediction of PEGylation Proteins Technology Market Research Report: Late …
This comprehensive Report of the PEGylation Proteins Technology Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. It represents a comprehensive and succinct analysis report of the main competitor and price statistics with a view to helping beginners establish their place…
PEGylation Market Size and Forecast Estimate of Top Manufacturers with Share and …
Latest released, the research study on Global PEGylation Market Research Report 2021, report comprises growth rate, size, analysis by type, market segment by Application, market competition by manufacturers, share by region, manufacturing cost analysis, Also, the PEGylation Market offers market breakdown, competitive situation and trends, key raw materials analysis, dynamics, forecast by type, by application and revenue estimates with covid-19 impact till 2026.
Get Free sample copy of the report Here:
https://www.marketintelligencedata.com/reports/918200/global-pegylation-market-growth-2021-2026/inquiry?Mode=kalyani
The…
PEGylation Market 2021| Global Leading Players, Industry Updates, Future Growth, …
"Market Summary
A newly published report titled “(PEGylation Market)” by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario, market entry strategies, best industry practices, pricing strategy, technology landscape, and consumption,…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
New study: PEGylated Proteins Market Trends, Business Strategies and Opportuniti …
The process of chaining or modification of biological molecules by conjugation with non-immunogenic polymer and nontoxic polyethylene glycol to improve or modify the physicochemical property of molecule is known as PEGylation. PEGylation improves stability and solubility of drug and decreases immunogenicity by changing the electrostatic binding, confirmation, and hydrophobicity of the molecule. PEGylation decreases the dose frequency by reducing renal excretion and proteolysis, and increases tension time of conjugates in…
